Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy?
Background: Acute macular neuroretinopathy (AMN) is an increasingly diagnosed disorder associated with several diseases. The aim of this study was to report the incidence of AMN cases diagnosed during the 2020 coronavirus disease 2019 (COVID-19) pandemic year in a French hospital, and to describe th...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a724e53c6d9f469ba587e68425a114d2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a724e53c6d9f469ba587e68425a114d2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a724e53c6d9f469ba587e68425a114d22021-11-11T17:39:33ZDid the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy?10.3390/jcm102150382077-0383https://doaj.org/article/a724e53c6d9f469ba587e68425a114d22021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5038https://doaj.org/toc/2077-0383Background: Acute macular neuroretinopathy (AMN) is an increasingly diagnosed disorder associated with several diseases. The aim of this study was to report the incidence of AMN cases diagnosed during the 2020 coronavirus disease 2019 (COVID-19) pandemic year in a French hospital, and to describe their different forms. Methods: All patients diagnosed between 2019 and 2020, in Paris Rothschild Foundation Hospital, with AMN, paracentral acute middle maculopathy (PAMM) and multiple evanescent white dot syndrome (MEWDS) were retrospectively collected using the software Ophtalmoquery<sup>®</sup> (Corilus, V1.86.0018, 9050 Gand, Belgium). Systemic and ophthalmological data from AMN patients were analyzed. Results: Eleven patients were diagnosed with AMN in 2020 vs. only one patient reported in 2019. The incidence of AMN significantly increased from 0.66/100,000 visits in 2019 to 8.97/100,000 visits in 2020 (<i>p</i> = 0.001), whereas the incidence of PAMM and MEWDS remained unchanged. Four (36%) of these AMN patients were tested for COVID-19 and received positive polymerase chain reaction (PCR) tests. Conclusions: The incidence of AMN cases increased significantly in our institution in 2020, which was the year of the COVID-19 pandemic. All AMN-tested patients received a positive COVID PCR test, suggesting a possible causative link. According to the different clinical presentations, AMN may reflect different severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pathogenic mechanisms.Georges AzarSophie BonninVivien VasseurCéline FaureFlore SalviatCatherine Vignal ClermontCherif TitahSelim FarèsElise BoulangerSabine DerrienAude CouturierAmélie DuvilliersAnthony ManasseroRabih HageRamin TadayoniFrancine Behar-CohenMartine Mauget-FaÿsseMDPI AGarticleacute macular neuroretinopathyAMNCOVID-19SARS-CoV-2retinaOCT angiographyMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5038, p 5038 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
acute macular neuroretinopathy AMN COVID-19 SARS-CoV-2 retina OCT angiography Medicine R |
spellingShingle |
acute macular neuroretinopathy AMN COVID-19 SARS-CoV-2 retina OCT angiography Medicine R Georges Azar Sophie Bonnin Vivien Vasseur Céline Faure Flore Salviat Catherine Vignal Clermont Cherif Titah Selim Farès Elise Boulanger Sabine Derrien Aude Couturier Amélie Duvilliers Anthony Manassero Rabih Hage Ramin Tadayoni Francine Behar-Cohen Martine Mauget-Faÿsse Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? |
description |
Background: Acute macular neuroretinopathy (AMN) is an increasingly diagnosed disorder associated with several diseases. The aim of this study was to report the incidence of AMN cases diagnosed during the 2020 coronavirus disease 2019 (COVID-19) pandemic year in a French hospital, and to describe their different forms. Methods: All patients diagnosed between 2019 and 2020, in Paris Rothschild Foundation Hospital, with AMN, paracentral acute middle maculopathy (PAMM) and multiple evanescent white dot syndrome (MEWDS) were retrospectively collected using the software Ophtalmoquery<sup>®</sup> (Corilus, V1.86.0018, 9050 Gand, Belgium). Systemic and ophthalmological data from AMN patients were analyzed. Results: Eleven patients were diagnosed with AMN in 2020 vs. only one patient reported in 2019. The incidence of AMN significantly increased from 0.66/100,000 visits in 2019 to 8.97/100,000 visits in 2020 (<i>p</i> = 0.001), whereas the incidence of PAMM and MEWDS remained unchanged. Four (36%) of these AMN patients were tested for COVID-19 and received positive polymerase chain reaction (PCR) tests. Conclusions: The incidence of AMN cases increased significantly in our institution in 2020, which was the year of the COVID-19 pandemic. All AMN-tested patients received a positive COVID PCR test, suggesting a possible causative link. According to the different clinical presentations, AMN may reflect different severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pathogenic mechanisms. |
format |
article |
author |
Georges Azar Sophie Bonnin Vivien Vasseur Céline Faure Flore Salviat Catherine Vignal Clermont Cherif Titah Selim Farès Elise Boulanger Sabine Derrien Aude Couturier Amélie Duvilliers Anthony Manassero Rabih Hage Ramin Tadayoni Francine Behar-Cohen Martine Mauget-Faÿsse |
author_facet |
Georges Azar Sophie Bonnin Vivien Vasseur Céline Faure Flore Salviat Catherine Vignal Clermont Cherif Titah Selim Farès Elise Boulanger Sabine Derrien Aude Couturier Amélie Duvilliers Anthony Manassero Rabih Hage Ramin Tadayoni Francine Behar-Cohen Martine Mauget-Faÿsse |
author_sort |
Georges Azar |
title |
Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? |
title_short |
Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? |
title_full |
Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? |
title_fullStr |
Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? |
title_full_unstemmed |
Did the COVID-19 Pandemic Increase the Incidence of Acute Macular Neuroretinopathy? |
title_sort |
did the covid-19 pandemic increase the incidence of acute macular neuroretinopathy? |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/a724e53c6d9f469ba587e68425a114d2 |
work_keys_str_mv |
AT georgesazar didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT sophiebonnin didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT vivienvasseur didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT celinefaure didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT floresalviat didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT catherinevignalclermont didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT cheriftitah didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT selimfares didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT eliseboulanger didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT sabinederrien didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT audecouturier didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT amelieduvilliers didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT anthonymanassero didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT rabihhage didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT ramintadayoni didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT francinebeharcohen didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy AT martinemaugetfaysse didthecovid19pandemicincreasetheincidenceofacutemacularneuroretinopathy |
_version_ |
1718432017898536960 |